Del 163

Progress in Molecular Biology and Translational Science

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B

Inbunden, Engelska, 2019

Av Zhang,Lijua, Lijuan Zhang

2 419 kr

Beställningsvara. Skickas inom 7-10 vardagar
Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)


Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases-30 Years Clinical Applications in China, and more.



  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field

Produktinformation

  • Utgivningsdatum2019-04-26
  • Mått152 x 229 x 34 mm
  • Vikt970 g
  • FormatInbunden
  • SpråkEngelska
  • SerieProgress in Molecular Biology and Translational Science
  • Antal sidor551
  • FörlagElsevier Science
  • MedarbetareZhang,Lijuan
  • ISBN9780128177402